OILY SKIN WITH VISIBLE AND ENLARGED PORES,
PRONE TO EXCESSIVE SHINE
SHINE, VISIBLE PORES

Validity after opening:
12 Months
  • Tube
  • Adults
    Teenagers
  • Anti-enlarged pores
    Mattifying
  • Face
Volume
3337872413025

40 ml

bag

IT'S PROVEN
DOUBLE ACTION

pourcentage 90
ANTI-SHINE ACTION*
100% No oily film
94% Skin is instantly mattified
90% Day after day, skin is mattified

 

Bar
PORE-MINIMIZING ACTION*
94% Skin texture is more refined
76% Pores are tightened
76% Pores are less visible

*Cosmetoclinical test under dermatological supervision, auto-evaluation immediately and after 4 weeks.

EXPERT
QUOTE

Avoid touching skin or imperfections. Keep nails short. Avoid sun exposure that can worsen blemishes.

WHICH ONE
DO YOU NEED?

EFFACLAR
MAT

Sebo-controlling moisturiser anti-shine anti-enlarged poresface care
La Roche Posay Face Care Effaclar Mat Sebo Controlling Moisturizer 40m

OR

EFFACLAR
K (+)

Oily skin renovating care anti-oxidation 8hr anti-sebum facial care anti-blackheads
LaRochePosayFaceCareEffaclarK30ml3337872419638Front

THE PERFECT MATCH
FOR YOUR SKIN

THE EFFACLAR WINNING TRIO

EFFACLAR is a complete range of anti-imperfection solutions that targets all the stages of the imperfection life cycle with a high efficacy, while ensuring a perfect tolerance.
PERSISTENT SHINE

SPOTSCAN+
FOR ACNE-PRONE SKIN
INSTANT SKIN ANALYSIS
POWERED BY AI
DEVELOPED 
WITH DERMATOLOGISTS

Our skin analysis tool combines La Roche Posay’s dermatological expertise with A.I. to find the best routine for your acne-prone skin.

DISCOVER THE OTHER
PRODUCTS OF THE RANGE

EFFACLAR is a complete range of anti-imperfection solutions that targets all the stages of the imperfection life cycle with a high efficacy, while ensuring a perfect tolerance.

WHAT ARE THE DIFFERENT
TYPES OF ACNE?

What are the first signs of acne? How to get rid of it?

Did you
know?

DidYouKnow_Desktop_1

The 3-step EFFACLAR routine
– cleanse, correct, protect – shows proven effectiveness
on patients with acne-prone skin living in polluted environments.*

*Quantitative study, Beijing/Shanghai, 2014, Total sample: n=600 ²DIM Sell-in YTD Sept 2015 ³INS/Kantar Health La Roche-Posay Barometers 2013